glp 1 monthly weight loss GLP-1/GIP Results After 1, 3, and 6 Months My GLP-1 WeightLoss Journal 2024:

Tirzepatide typically produces far more than 5-10% weight loss

In large-scale studies, semaglutide (the active ingredient in Ozempic and Wegovy) led to an average placebo-corrected weight loss of about 12.4% at the 2.4 mg dose

Increased insulin production and secretion from beta cells and inhibition of GCG release from alpha cells in the pancreas are the primary effects of GLP-1 acting via certain GLP-1 receptors found on certain bodily tissues, including the pancreas

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide

Street estimates peg Dr Reddys semaglutide sales at $100300 million in FY27FY28